Why the study?
Minimizing perioperative stress is critical to reducing fatal arrhythmias in patients with CPVT undergoing procedures.
Does dexmedetomidine intravenous sedation prevent arrhythmias and maintain stability in a patient with CPVT undergoing oral surgery?
Does dexmedetomidine intravenous sedation prevent arrhythmias and maintain stability in a patient with CPVT undergoing oral surgery?
Dexmedetomidine-based intravenous sedation may provide safe sympatholytic effects and cardiovascular stability for patients with CPVT undergoing stressful procedures like oral surgery.
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare inherited arrhythmogenic disorder induced by adrenergic stress. Electrophysiologically, it is characterized by emotional stress- or exercise-induced bidirectional ventricular tachycardia that may result in cardiac arrest. Minimizing perioperative stress is critical as it can reduce fatal arrhythmias in patients with CPVT. Dexmedetomidine (DEX), a centrally acting sympatholytic anesthetic agent, was used in the successful intravenous (IV) moderate sedation of a 27-year-old female patient with CPVT, a history of cardiac events, and significant dental fear and anxiety scheduled to undergo mandibular left third molar extraction. Oral surgery was successfully performed under DEX-based IV sedation to reduce stress, and no arrhythmias were observed. IV sedation with DEX provided a sympatholytic effect with respiratory and cardiovascular stability in this patient with CPVT who underwent oral surgery.
No takes yet. Share an insight, caveat, or question.
Shionoya et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: